Hemoglobin spray aids diabetic foot ulcer (DFU) healing when combined with standard wound care. Here are the results of a study of 20 patients with DFU 12 wk or longer seen at a single UK wound care clinic, treated with hemoglobin spray in addition to standard wound care and followed for 6 mo. Wound healing outcomes were compared retrospectively to a similar cohort treated the previous year:
There was a median of 63% wound healing with hemoglobin spray by week 4, with 5 patients (25%) completely healed, vs 26% and just 1 patient, respectively, during the control period (p=.03). By week 16, wound size reduction was 91% with spray vs 43% control, (p=.01), and by week 28, 95% vs 63%, respectively (p=.02). Slough and exudate levels were also significantly reduced with the spray compared to control patients.
Source: Hunt SD, Elg F. Clinical effectiveness of hemoglobin spray (Granulox(®)) as adjunctive therapy in the treatment of chronic diabetic foot ulcers. Diabet Foot Ankle. 2016;7:33101. doi: 10.3402/dfa.v7.33101. PMID: 27829487 via Univadis [11/15/16]